The Securities and Exchange Commission settled charges Friday against Mylan N.V., who agreed to pay $30 million for accounting and disclosure failures relating to a civil...
(Reuters) - The U.S. Securities and Exchange Commission on Friday sued Mylan NV (O:MYL), accusing it of failing to timely disclose a possible loss related to a Department of...
Mylan N.V. ([[MYL]] -0.3%) is under modest pressure on below-average volume in early trade in apparent response to a rumored SEC lawsuit over its lack of d
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Mylan (NASDAQ:MYL), which...
Theravance Biopharma, Inc. (NASDAQ:TBPH) is a biopharmaceutical company focused on developing treatments targeting various therapeutic areas such as infectious, respiratory,...
Shares of Johnson & Johnson (NYSE:JNJ) gained 1.6% after it announced a settlement agreement with Cuyahoga and Summit counties related to the multidistrict opioid litigation...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Sell||Neutral||Neutral||Sell||Strong Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Buy||Strong Sell||Strong Sell|
|Summary||Strong Sell||Sell||Buy||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Inside Up||1D||Current|
|Bullish doji Star||1W||Current|
|Three Inside Up||5H||1||Oct 11, 2019 06:00AM|
|Falling Three Methods||1D||3||Oct 08, 2019|
|Falling Three Methods||15||3||Oct 11, 2019 03:00PM|
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.Read More
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.